Using an “Exercise Is Medicine” approach, the Dieli-Conwright Laboratory is centered on testing personalized exercise interventions to improve cancer outcomes among individuals across the lifespan diagnosed with cancer.
Rooted in clinical exercise physiology, our research examines mechanisms by which post-diagnosis exercise can impact cancer outcomes, with a specific focus on biomarkers related to body composition, inflammation, metabolic dysregulation, and cognition. We derive randomized controlled trials to test whether various types of prescriptive exercise improve cancer outcomes in individuals from diverse racial and ethnic backgrounds diagnosed with cancer across the lifespan, from adolescents and young adults to older adults.
Rooted in clinical exercise physiology, our research examines mechanisms by which post-diagnosis exercise can impact cancer outcomes, with a specific focus on biomarkers related to body composition, inflammation, metabolic dysregulation, and cognition. We derive randomized controlled trials to test whether various types of prescriptive exercise improve cancer outcomes in individuals from diverse racial and ethnic backgrounds diagnosed with cancer across the lifespan, from adolescents and young adults to older adults.
|
|
|